205 related articles for article (PubMed ID: 30381291)
41. Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype.
Spender LC; Cornish GH; Sullivan A; Farrell PJ
J Virol; 2002 May; 76(10):4919-27. PubMed ID: 11967309
[TBL] [Abstract][Full Text] [Related]
42. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes.
Zimber-Strobl U; Strobl LJ
Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604
[TBL] [Abstract][Full Text] [Related]
43. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.
Kempkes B; Spitkovsky D; Jansen-Dürr P; Ellwart JW; Kremmer E; Delecluse HJ; Rottenberger C; Bornkamm GW; Hammerschmidt W
EMBO J; 1995 Jan; 14(1):88-96. PubMed ID: 7828599
[TBL] [Abstract][Full Text] [Related]
44. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
Chen X; Kamranvar SA; Masucci MG
Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
[TBL] [Abstract][Full Text] [Related]
45. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ
PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782
[TBL] [Abstract][Full Text] [Related]
46. Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization.
Hansen KD; Sabunciyan S; Langmead B; Nagy N; Curley R; Klein G; Klein E; Salamon D; Feinberg AP
Genome Res; 2014 Feb; 24(2):177-84. PubMed ID: 24068705
[TBL] [Abstract][Full Text] [Related]
47. Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation.
Ali AK; Saito S; Shibata S; Takada K; Kanda T
J Virol; 2009 Sep; 83(18):9163-74. PubMed ID: 19570868
[TBL] [Abstract][Full Text] [Related]
48. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
[TBL] [Abstract][Full Text] [Related]
49. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
50. Roles of RUNX in B Cell Immortalisation.
West MJ; Farrell PJ
Adv Exp Med Biol; 2017; 962():283-298. PubMed ID: 28299664
[TBL] [Abstract][Full Text] [Related]
51. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
Groves AK; Cotter MA; Subramanian C; Robertson ES
J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
[TBL] [Abstract][Full Text] [Related]
52. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
53. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
Beer S; Wange LE; Zhang X; Kuklik-Roos C; Enard W; Hammerschmidt W; Scialdone A; Kempkes B
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2200512119. PubMed ID: 35857872
[TBL] [Abstract][Full Text] [Related]
54. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.
Siouda M; Frecha C; Accardi R; Yue J; Cuenin C; Gruffat H; Manet E; Herceg Z; Sylla BS; Tommasino M
PLoS Pathog; 2014 May; 10(5):e1004125. PubMed ID: 24809689
[TBL] [Abstract][Full Text] [Related]
56. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells.
Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J
Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166
[TBL] [Abstract][Full Text] [Related]
57. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.
Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690
[TBL] [Abstract][Full Text] [Related]
58. Efficient foreign gene expression in Epstein-Barr virus-transformed human B-cells.
Curiel TJ; Cook DR; Bogedain C; Jilg W; Harrison GS; Cotten M; Curiel DT; Wagner E
Virology; 1994 Feb; 198(2):577-85. PubMed ID: 8291240
[TBL] [Abstract][Full Text] [Related]
59. RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth.
Gunnell A; Webb HM; Wood CD; McClellan MJ; Wichaidit B; Kempkes B; Jenner RG; Osborne C; Farrell PJ; West MJ
Nucleic Acids Res; 2016 Jun; 44(10):4636-50. PubMed ID: 26883634
[TBL] [Abstract][Full Text] [Related]
60. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]